Navigation Links
finalized in Medical News

Sale of Enzymatic Therapy, Inc. to Nature's Way Holding Company Finalized

Nature's Way Holding Company names Randy J. Rose President/CEO and Rory Mahony Chief Operating Officer of new natural medicine powerhouse GREEN BAY, Wis., Nov. 10 /PRNewswire/ -- Representatives of the Dr. Willmar Schwabe Group, of Karlsruhe, Germany, have confirmed that corporate ownership ...

New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011

... are and whether or not they are in the best interest of dialysis patients. Although exact details of the bundled payment system have yet to be finalized and made official, Medical Directors and Renal Administrators are clearly concerned about the impact of these changes on the fiscal health (and viabil...

Alegent Health Turns to ThinIdentity(TM) to Improve Caregiver Productivity

...ccess to patient data was significant in a successful implementation and ongoing adoption by physicians." Installation of ThinIdentity is being finalized at Alegent Health Lakeside Hospital's emergency department. "Alegent Health is at the forefront of information technology initiatives and the ThinIden...

Surrogacy and Egg Donation Seminar with Free Egg Donation Cycle

...he is also the author of Assisted Reproduction, the Complete Guide to Having a Baby with the Help of a Third Party . Her next book is currently being finalized for publication. Attorney Erickson is also the host of The Surrogacy Lawyer Radio Show which airs weekly at BlogTalkRadio.com and discusses topics ...

Secure eHealth and DRM Security Partner to Provide Most Secure Healthcare Network Available

...protection, with multiple layers of security while not limiting access, CIFRA does this perfectly." It is expected that the agreement will be finalized in the coming weeks at which time a formal announcement will be made. Secure eHealth, formerly Envoii Healthcare is a provider of leading edge securit...

Prince William Health System Completes Merger With Novant Health to Expand Quality Health Care in Northern Virginia

...al, Prince William Health System (PWHS) of Manassas, Va. and Novant Health of North Carolina, both non-profit organizations, announced today they have finalized an agreement to merge. Novant will invest more than $240 million to help PWHS continue to meet the increasing health care needs of western Prince Will...

Positive CHMP Opinion for JAVLOR(R) in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen

... new bi-fluorinated MTI (Microtubule inhibitor) obtained by chemistry exploiting the reactivity of Vinca scaffold in superacidic media. Such strategy, finalized in collaboration with experts at the University of Poitiers (France), enabled the selective introduction of two fluorine atoms in a part of that struc...

Living Cell Technologies' Diabetes Clinical Trial Authorized by New Zealand Government

...al Ethics Committee formally accept the changes required by the Minister. LCT CEO Dr Paul Tan said: "We are pleased that the conditions have been finalized and LCT looks forward to commencing the trial within the next two months with the acceptance of the changes by the Ethics Committee." Professor B...

Bioniche Provides a Corporate Update

...s to address its short-term liquidity requirements, and progress is being made on these initiatives. It is not expected that these initiatives will be finalized before June 30, 2009, but Valens U.S. has agreed to have the credit facility return to "on demand" status. About Bioniche Life Sciences Inc. ...

InfoLogix and HIA Advise Hospitals How to Obtain Maximum Share of $19B Healthcare Stimulus

...us funding earmarked by the American Recovery and Reinvestment Act (also known as the ARRA). Even as the pivotal definition of "meaningful use" is finalized by the White House and Congress , it's crucial that hospital administrators take definitive steps to be positioned to receive maximum funding. ...
finalized in Medical Technology

Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US

...cial development." Pivotal phase 3 protocols for very high triglycerides and phase 2 protocols for statin combination therapy are currently being finalized with input from experts and the FDA in parallel with partnering discussions. About DCCR DCCR, diazoxide choline controlled release, is an AT...

Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes

...ovo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) has finalized its discussions of questions related to liraglutide, a once-daily human GLP-1 analogue. The Advisory Committee voted on questions related to the...

Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997

...the anti-tumor properties of CYT997. Analysis of biological and clinical data from the study is currently ongoing and the company expects to present a finalized trial report, including a complete list of adverse events and the recommended dose for Phase II studies, within three months. The following ...

Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test

...ire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM) today announced they have finalized a transaction, pursuant to their signed Letter of Intent announced December 2, 2008 (see "Transgenomic Signs Letter of Intent for an Agreement to Excl...

Alfacell Provides ONCONASE(R) NDA Submission Update

...of the ONCONASE rolling NDA for patients that have failed prior chemotherapy. Therefore, the final components of the rolling ONCONASE NDA will not be finalized until Alfacell receives guidance from the FDA at the pre-NDA meeting. Alfacell expects to provide an update on the planned completion of the rolling ...

New Bisphenol A Study Has Limited Capability to Assess Human Health Effects

...f food-contact products containing bisphenol A, will be peer-reviewed by a subcommittee of the FDA Science Board on September 16 and is expected to be finalized later this year. http://www.americanchemistry.com The American Chemistry Council (ACC) represents the leading companies engaged in the business ...

Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center

...se III multi-center study is led by the National Cancer Institute (NCI) and is enrolling at cancer centers throughout the United States. Delcath has finalized a clinical research agreement with St. Luke's. Sanjiv Agarwala, M.D., Chief of Oncology and Hematology, will serve as the Principal Investigator of th...

IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study

...h 20 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (the Company) (Nasdaq: IDMI ) announced today that it has initiated enrollment in a clinical protocol finalized with the U.S. Food and Drug Administration (FDA), which provides mifamurtide (L-MTP-PE) to eligible, high-risk osteosarcoma patients through a compass...

Anti-Cancer Drug CYT997 Update

...stration in 2005 to commence Phase I studies. During the 2008 financial year Cytopia has: -- commenced dosing in its first Phase II study -- finalized preparations for its second Phase II study -- concluded its first Phase I safety and tolerability study with intravenous administration -- co...

Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study

...priate venue to help train diabetes educators about the effectiveness of Medifast Meal Replacements in the treatment of type 2 diabetes. The study was finalized for publication within the last 12 months after being presented to physicians and scholars attending the American Diabetes Association Convention in 2...
finalized in Medical Products

TrackDoc Automated Medical Information Solutions

Description:... last name, patient ID number, facility, date of service, date of dictation, etc.). Logins are available for coders as well, since they can code from finalized documents and fax as needed for expedient payment processing. ZyDoc offers full service medical transcription solutions. We have experienced month-...
Company:ZyDoc Medical Transcription, LLC

ChartLogic Neurology Electronic Medical Office

Features:...ur patients Diagnosis Director - Associates diagnosis with CPT codes, macros, patient education and prescriptions allowing assessment and plan to be finalized in one step DataCatch - Extracts basic patient demographic information from your practice management system and imports into ChartLogic™ Int...
Company:ChartLogic

ChartLogic Urology Electronic Medical Office

Features:...ur patients Diagnosis Director - Associates diagnosis with CPT codes, macros, patient education and prescriptions allowing assessment and plan to be finalized in one step DataCatch - Extracts basic patient demographic information from your practice management system and imports into ChartLogic™ Inte...
Company:ChartLogic

ChartLogic Orthopaedic Surgery Electronic Medical Office

Features:...ur patients Diagnosis Director - Associates diagnosis with CPT codes, macros, patient education and prescriptions allowing assessment and plan to be finalized in one step DataCatch - Extracts basic patient demographic information from your practice management system and imports into ChartLogic™ Inte...
Company:ChartLogic

ChartLogic Ophthalmology Electronic Medical Office

Features:... patients Diagnosis Director - Associates diagnosis with CPT codes, macros, patient education and prescriptions allowing assessment and plan to be finalized in one step DataCatch - Extracts basic patient demographic information from your practice management system and imports into ChartLogic Interf...
Company:ChartLogic

ChartLogic Optometry Electronic Medical Office

Features:... patients Diagnosis Director - Associates diagnosis with CPT codes, macros, patient education and prescriptions allowing assessment and plan to be finalized in one step DataCatch - Extracts basic patient demographic information from your practice management system and imports into ChartLogic Interf...
Company:ChartLogic

ChartLogic™ Cardiology Electronic Medical Office

Features:...ur patients Diagnosis Director - Associates diagnosis with CPT codes, macros, patient education and prescriptions allowing assessment and plan to be finalized in one step DataCatch - Extracts basic patient demographic information from your practice management system and imports into ChartLogic™ Int...
Company:ChartLogic
finalized in Biological News

ACS Technologies(TM) Selects M2SYS for Innovative Biometric Software

... ATLANTA, July 7 /PRNewswire/ -- M2SYS Technology, an award-winning biometric technology research and development firm, announced today that it has finalized an agreement with ACS Technologies, the leading provider of information management solutions to nearly 50,000 churches, schools, and other faith-based...

NEWSLETTER: Antibody Fragment Production Breakthrough with 2nd Generation EBA

... today a technological breakthrough in the field of purification of antibody fragments from an E. coli expression system. Richter-Helm BioLogics has finalized the downstream process for Phase III clinical trial material using 2nd Generation Expanded Bed Adsorption (EBA) technology developed by the Danish bio...

BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008

...owth in 2009 that will enable us to maintain our momentum," stated DePasquale. "Several large pending biometrics awards are reportedly close to being finalized that should catalyze activity in this space. In addition, we continue to see ongoing and growing interest in our Law Enforcement solutions despite th...

Paradigm Tactical Products to be Largest Distributor of Metal/Radiation Detection Wands in United States

...nd metal detection wand and four additional detector models in the United States. In addition an on going Global Master Distributor discussion will be finalized by the new year. The newest products to be distributed by Paradigm are complementary to its recently announced RadSafe(TM) and StealthSensor (TM) pr...

M2SYS Technology Selected by ZOLL Data Systems to Integrate Fingerprint Software

... ATLANTA, July 10 /PRNewswire/ -- M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that it has finalized a partnership agreement with ZOLL Data Systems(R), an industry leader in the development of EMS and fire department management software, to provide fi...

Researchers discover protein that controls bone growth

...g-based therapies." Most of the research was initially carried out at Phenogene and Enobia Pharma, two Montreal-based biotech companies, but it was finalized in Dr. Moffatts lab at the Shriners Hospital for Children in Montreal. This fundamental research could pave the way to the rationalized design of n...
finalized in Biological Technology

Sale of Norlight Telecommunications is finalized

Milwaukee, Wis. - Journal Communications has completed its $185 million sale of Norlight Telecommunications to Q-Comm Corp . of Evansville, Ind. The sale, subject to federal and state regulatory approvals, is expected to take four to six months to complete. Journal Communications said...

NeurogesX Reports Second Quarter 2009 Results

...eral neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain. Following the approval, NeurogesX finalized an exclusive agreement with Astellas Pharma Europe Ltd. (Astellas) for the commercialization of Qutenza in the European Economic Area (EEA), including...

Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights

... ANA598 ANA598 is the Company's non-nucleoside HCV polymerase inhibitor. Finalization of ANA598 Phase II Protocol. Anadys has finalized its protocol and received FDA clearance for the Phase II study of ANA598 in combination with pegylated interferon-alpha and ribavirin for the treatmen...

Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009

... 2008. - As at June 30, 2009 the capital resources totalled 175,4m DKK (23,6m EUR). - In Q2 the SPC3649 compound targeting hepatitis C finalized a single dose First/In/Man study with encouraging results and a multiple ascending dose study in healthy volunteers is scheduled to commen...

Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain

... of Europe, Latin America, and Africa. Details of the commercial terms between ROVI and Novavax will be announced after the definitive agreements are finalized and are expected to include milestones and royalties. Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax, stated: "We are honor...

BioLife Solutions Announces Validation and Start-Up of New Internal Manufacturing Facility for Serum-Free Cell and Tissue Biopreservation Media Products

...a products. BioLife's Quality System and nearly 6,000-square-foot GMP production facility incorporates a uni-directional workflow design that was finalized with the input of several clean room consultants and members of BioLife's Quality, Scientific and Regulatory Advisory Board. The facility consists of...

Amylin Announces Preliminary Tabulation of Annual Meeting Results

...al medicines to patients and to drive sustainable and profitable growth. Voting results on Director elections and all proposals will be finalized once they are certified by the Inspector following a customary review and challenge period. A final tally of the votes will be published in the Compa...

Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer

...ael and an MBA, Magna Cum Laude, from New York University's Stern Graduate School of Business. The terms of Mr. Bentsur's employment are being finalized and will be set forth in an employment agreement with the Company. As an inducement to his employment, the Company has granted Mr. Bentsur options to...

Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA

...that the agency has released the Company's CD-NP development program from clinical hold. As the next step, the Company will submit to the FDA the finalized protocol for the Company's planned 30-patient single-blind, placebo-controlled Phase 2 study designed to provide additional information on the safety ...

Insmed Announces First Quarter 2009 Financial Results

...ed results for the first quarter ended March 31, 2009. Recent Company Highlights Follow-on Biologics Program finalized sale of follow-on biologics (FOB) assets to Merck & Co., Inc., through an affiliate, for gross proceeds of $130 million; and Net of fi...
Other Tags
(Date:7/25/2014)... July 25, 2014 Ticket Down ... Inter Milan tickets in Berkeley at California Memorial Stadium. ... new fans of football, the organizers of the 2014 Guinness ... club teams to North America. With teams representing La Liga, ... will bring some of the best football players from around ...
(Date:7/25/2014)... 25, 2014 On July 22, ... Media client and the nation’s number one provider ... handbooks, announced their partnership with TransAct Merchant Solutions’ ... registered ISO/MSP of Chase Paymentech Solutions, LLC, which ... industry. Companies that are members of TransAct’s National ...
(Date:7/25/2014)... Hastings and Hastings, a personal injury ... to personal injury claims, announces free initial consultations. Hastings ... services for those that have been injured as a ... Free initial consultation services gives clients’ greater flexibility in ... personal injury claim . It also offers clients the ...
(Date:7/25/2014)... News) -- Shift workers, especially men, may be at higher ... such schedules, a new study suggests. Also at special ... schedule, with shifts moving around at various times of the ... one expert, Dr. Alan Manevitz, a clinical psychiatrist at Lenox ... known that working shifts disrupts many key body chemicals, creating ...
(Date:7/25/2014)... protect vulnerable neurons and reduce motor deficits in ... Emory University School of Medicine have shown. , ... of Parkinson,s Disease . , The findings demonstrate ... brain at sufficient levels and have beneficial effects ... shot. Previous studies of XPro1595 in animals tested ...
Breaking Medicine News(10 mins):Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:Nuanced Media Client, CEDR HR Solutions, Partners with TransAct to Serve Medical, Dental, and Eye Care Professionals 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3Health News:Study Links Shift Work to Risk for Type 2 Diabetes 2Health News:Study Links Shift Work to Risk for Type 2 Diabetes 3Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2
(Date:7/24/2014)... where electric cars ply silent freeways, solar panels blanket ... the earth, from howling winds and from the blazing ... it is technically and economically feasible to convert California,s ... energy. Published in Energy , the plan shows ... supply in California that could create tens of thousands ...
(Date:7/24/2014)... of researchers has developed a new nanoscale agent for ... for assessing the function and properties of the GI ... and treatment of gut diseases. , Illnesses ... and inflammatory bowel disease all occur in the intestine ... with diseases such as diabetes and Parkinson,s. , ...
(Date:7/24/2014)... this week for an all-day public forum on a ... (EPA) to dredge toxic sediment from an eight-mile stretch ... called the plan, which proposes removing 4.3 million cubic ... riverbed, one of the largest cleanups in the agency,s ... off-site. , "We need to ensure the future well-being ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4New imaging agent provides better picture of the gut 2Experts Weigh the Pros and Cons of a $1.7 Billion EPA Cleanup Plan for the Passaic River at an NJIT 2
Other Contents